Capsaicinoids Modulating Cardiometabolic Syndrome Risk Factors: Current Perspectives

Table 2

Capsaicinoids effects on potential markers of weight management.

Markers (number of positive studies/total studies reported)	Capsaicin/capsaicinoids dose	Potential biological effects
Energy expenditure ( studies)	3–30 mg/d	Increase in EE for 30 min [12, 22–25, 27, 36, 51, 64], [15]
Lipid oxidation and fat loss (15/18 studies)	1–30 mg/d	Increase in lipid oxidation and decreased abdominal/body fat [13, 18, 22–24, 27], [15]
Lipolysis (1/1)	2 mg	Tolerable dose, increased plasma FFA (2 hr and 2.5 hr), and glycerol (4 hr) concentrations [16]
Appetite (7/9 studies)	2–30 mg	Decrease in appetite, decrease in energy intake, and increase in satiety [13, 20–23, 28, 36, 49]
Weight management markers (3/3)	2 mg	Body indices (waist circumference, hip circumference, and WHR); appetite; lipolysis [16, 28, 49]

Cross reference.